Versigent Q2 EPS $1.92 Beats $1.35 Estimate, Sales $2.444B Beat $2.313B Estimate
Versigent (NYSE:VGNT) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.35 by 42.22 percent. The company reported quarterly sales of $2.444 billion which beat the analyst
Versigent made way more money than experts thought it would—earnings were 42% higher, and sales were also bigger. When a company beats expectations like this, it can show the business is doing better than people predicted.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.